| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |